Back to search
FDAFDA · Food and drugs·Recall number D-1542-2022

Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A

Published October 5, 2022 · Recall initiated: September 21, 2022

Summary

FDA records drug Class II recall D-1542-2022, published October 5, 2022 and initiated September 21, 2022. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 3,931 cartons; Lot: Lot 7105130, exp 9/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Viatris Inc
Distributor
Nationwide in the USA
Lot
Lot 7105130, exp 9/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A recalled?

Yes. FDA published recall D-1542-2022 on October 5, 2022. Reported hazard: Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter